Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.
Purpose: Hepatic veno-occlusive disease (HVOD) is one of the major complications following hematopoietic stem cell transplantation (HSCT). Although high-dose busulfan is associated with the development of HVOD, the underlying molecular mechanisms are still unknown. Methods: Transcriptional gene regu...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 68; no. 6; pp. 923 - 936 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jun2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |